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Background: Potassium-enriched diets exert renal and cardiovascular protective effects, but the underlying
mechanisms are largely unknown.
Methods: Using the dorsal skinfold chamber model for intravital microscopy, we examined endothelium-
dependent vasorelaxation of precapillary resistance arterioles in response to acetylcholine or the NO donor
SNAP in awake mice. Experiments were performed in uni-nephrectomized one renin gene (Ren-1c) C57BL/6
mice (control group) and in mice having received a continuous administration of deoxycorticosterone acetate
and a dietary supplementation of 1% sodium chloride for 8 weeks (DOCA/salt group). An additional group of
DOCA/salt treated animals received a dietary supplement of 0.4% KCl for 3 weeks prior to the experiments
(DOCA/salt + potassium group).
Results: DOCA/salt treatment for 8 weeks resulted in hypokalemia, but blood pressure remained unchanged. In
DOCA/salt mice, relaxation of resistance arterioles was blunted in response to acetylcholine, and to a lesser ex-
tent to SNAP, suggesting endothelial dysfunction. Endothelium-dependent vasorelaxation was restored by the
potassium‐enriched diet.
Conclusion: This study is the ﬁrst to demonstrate a protective effect of potassium on endothelium-dependent va-
sorelaxation in the absence of confounding anti-hypertensive effects, as observed inmost animalmodels and the
clinical situation.Wepropose that the known cardio- and nephro-protective effects of potassiummight – at least
in part – be mediated by the salutary effects on endothelium-dependent arteriolar relaxation.
Introduction
The renal and cardiovascular protector effects of a potassium-
enriched diet have been described in large epidemiological studies
(Ascherio et al., 1992; Khaw and Barrett-Connor, 1987; Tobian, 1988),
as well as in diverse animal models (Ellis et al., 1992; Jin et al., 1999;
Kido et al., 2008; Wang et al., 2005), which have demonstrated
that dietary potassium supplementation prevented vascular and renal in-
jury caused by high salt intake. In this cardiovascular protector context, a
pivotal role has been assigned to the anti-hypertensive effects of potassi-
um, as well as to other vasoprotective mechanisms, such as the reduced
production of reactive oxygen species (Matsui et al., 2006) and the direct
inhibition of intimal hyperplasia (Kido et al., 2008). Several authors have
described a beneﬁcial effect of potassiumon the generation and release of
nitric oxide (NO; see Zhou et al., 1999; Zhou et al., 2000) and a restoration
of endothelium-dependent vasorelaxation has been shown in diverse hy-
pertensive rat models (Sudhir et al., 1993; Sugimoto et al., 1988; Zhou et
al., 1999). Yet, in these studies, the capacity of potassium supplementa-
tion to preserve endothelium-dependent vasorelaxation was always ac-
companied by a reduction of blood pressure in treated animals, making
it impossible to knowwhether the salutary effect of potassium on vascu-
lar functionwas direct orwhether itwas indirect, secondary to its antihy-
pertensive action. Ex vivo studies on explanted rings of muscular arteries
have not conclusively argued against this latter possibility because of the
artiﬁcial ex vivo conditions and the study of large caliber conductance
vessels that physiologically exert quite different functions than the
precapillary resistance arterioles that are operative in blood pressure reg-
ulation (Schaefer et al., 2012).
Several years ago,we have described amousemodel, which develops
striking cardiac and renal hypertrophywhen one renin genemice are fed
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a DOCA/salt diet, notably in the absence of arterial hypertension (Wang
et al., 2002), and in which cardiovascular pathology is completely
prevented by dietary potassium supplementation (Wang et al., 2005).
In contrast, two-renin gene mice do develop hypertension under the
same condition (Wang et al., 2002). We have hence asked the question
whether DOCA/salt treated one-renin mice might be suitable to demon-
strate a direct effect of potassium diet onendothelium-dependent vaso-
relaxation, in the absence of confounding anti-hypertensive effects. In
order to examine the relaxation of pre-capillary resistance arterioles
under conditions of an intact animal organism, we used intravital mi-
croscopy in mice chronically instrumented with a dorsal skinfold cham-
ber (Lehr et al., 1993; Schaefer et al., 2005). We show herein that DOCA/
salt treatment attenuates endothelium-dependent vasorelaxation
(in the absence of arterial hypertension) and that vasorelaxation is effec-
tively restored in potassium-supplemented mice.
Methods and materials
The studies described herein comply with appropriate ethical stan-
dards. All experiments have been announced to and approved by the
local Animal Care and Use Committee prior to the beginning of the
experiments. DOCA/salt model: as described previously (Wang et al.,
2002), seven week-old male C57BL/6J mice with one renin gene
(Ren-1c), weighing 24 to 26 g, were anesthetized with 1% halothane
mixedwith oxygen. A silicone tubeﬁlledwith 35 mgdeoxycorticosterone
acetate (DOCA, Sigma) with a release rate of about 0.5 mg/day was
implanted subcutaneously into the abdominal wall. The tap water was
supplemented with 1% NaCl (DOCA/salt group). Control mice also
underwent uni-nephrectomy without DOCA administration and without
the dietary salt supplement (tapwater group). Allmice received standard
maintenance chow, containing 3 mg Na+ and 7.5 mg K+/g (U.A.R.,
Villemoisson sur Orge, France) and were housed in a temperature- and
humidity-controlled room with an automatic 12:12 h light–dark cycle.
Three weeks before the intravital microscopic experiments, one
half of the DOCA/salt treated mice received an additional 0.4% KCl in
the salt-supplemented drinking water (DOCA/salt+potassium
group). The amount of daily water intake was measured and found
to be signiﬁcantly elevated in the two DOCA/salt groups, but with
no signiﬁcant differences between the animals with or without potas-
sium supplementation (Table 1). A total of 9–12 mice were entered
into each treatment group. All mice were investigated by intravital
microscopy (see below) after 8 weeks of DOCA/salt administration.
The tables and ﬁgures denote the exact number of animals that
were eventually analyzed in each treatment arm.
One day after completion of the intravital microscopic experiments,
blood pressure and heart rate were recorded intraarterially using a com-
puterizeddata-acquisition systemas reportedpreviously in detail (Wang
et al., 2002). For the placement of the intraarterial catheter, mice were
anesthetized via inhalation of 1% halothanewith oxygen. The right carot-
id artery was exposed in an area of approximately 4 mm and a PE-10
catheter ﬁlled with a heparin (300 IU/ml) saline solution was inserted
into the artery and ﬁxed by silk sutures. The catheter was then subcuta-
neously tunneled to exit at the back of the neck and ﬁxed with surgical
suture material to the titanium observation chambers (see below).
Mice were allowed 3 h to recover from the anesthesia and were then
placed in Plexiglas tubes for immobilization. Thirty minutes later, the ar-
terial line was connected to a pressure transducer and blood pressure
and heart rate were monitored every 20 s for 15–30 min.
After blood pressure measurements, 300 ml of blood was retrieved
from the carotid artery catheter in a 0.6 ml Multivette tube containing
gel/clot activator (Sarstedt, Nümbrecht, Germany). Serum sodium and
potassium levels weremeasured by ﬂame photometry (Instrumentation
LaboratoryModel 943,Milan, Italy). Pilot studies fromour laboratory had
shown that this procedure is signiﬁcantly less stressful for the animals
than the other techniques of blood sampling as evidenced by 6-fold or
2-fold lower plasma norepinephrine levels when compared to decapita-
tion or retroorbital plexus puncture, respectively (Grouzmann et al.,
2003). This is particularly important for the measurement of plasma
renin concentration and activity, which is notoriously difﬁcult to mea-
sure in a way that precludes artifacts due to anesthesia (Iversen and
Andersen, 1983) and stressful sampling conditions (Jiménez et al.,
1985). Plasma renin activity (PRA) and plasma renin concentration
(PRC) were measured as described previously in detail (Wang et al.,
2002). After blood pressure measurements and blood sampling, mice
were euthanized by an overdose of pentobarbital sodium.
For the intravital microscopic experiments, we used the dorsal
skinfold chamber preparation (Lehr et al., 1993). This model permits
the microscopic investigation of pre- and postcapillary microvessels and
of nutritional capillary perfusion in a ﬁne, striated skin muscle in
non-anesthetized animals (Lehr et al., 1993; Schaefer et al., 2005, 2012).
After completion of the DOCA/salt treatment, mice with a body weight
of 28–32 g were anesthetized with xylazine–ketamine and titanium ob-
servation chambers were implanted into the dorsal skinfold as described
previously in detail (Lehr et al., 1993). Two days after chamber implanta-
tion, the tissue within the observation chambers was examined at scan-
ning magniﬁcation (2×-fold magniﬁcation, using a Leica ES5 stereo
microscope, with 10× eyepieces, total magniﬁcation 20-fold) for signs
of inﬂammation (increased microvessel tortuosity and reduced blood
cell velocity), edema (incapacity to focus on microvessel edges) or ﬂow
obstruction (venous or venular dilation). Since we strictly applied these
criteria for what can be considered a chamber with physiological ﬂow
conditions, we eliminated 40% of the animals before the intravital micro-
scopic studies. This number compares well to experiences made in other
immunocompetent mouse species (C57BL/6, BALB/c, and ApoE KO, all
showing an elimination rate of around 40%, see Li and Förstermann,
2000; Schaefer et al., 2005), but was slightly higher when compared to
mice that are genetically hairless (nu/nu or nude, showing an elimination
rate of around 25%; see Lehr et al., 1993). It should be acknowledged that
the success rate of the chamber preparation depends largely on the qual-
ity of microsurgical technique and hence varies from experimentor to
experimentor (unpublished observation), and that unexpected results
are obtained in experiments in which the above described strict criteria
are neglected (Schäfer et al., 2005). To eliminate the effects of anesthesia
and direct surgical trauma on the microvasculature, a recovery period of
72–96 hwas allowedbetween the implantation of the observation cham-
bers and the intravitalmicroscopic investigations. For intravitalmicrosco-
py, awake mice were placed in a Plexiglas tube ﬁxed to a Plexiglas
platform under a diagnostic microscope (Leica Dialux-20, Fig. 1) and the
superfusion protocol performed as explained in detail in previous publi-
cations (Schaefer et al., 2005, 2012). For the intravital microscopic
Table 1
Mean arterial blood pressure (MAP), heart rate (HR), serum sodium and potassium levels, plasma renin activity (PRA), plasma renin concentration (PRC) and water intake in DOCA/
salt-treated one-renin gene mice. Data are mean±SEM of 10–12 animals per group, DOCA/salt versus control and versus DOCA/salt+potassium. *Pb0.05, **Pb0.01, ***Pb0.001,
one-way ANOVA analysis followed by a Newman–Keuls test.
MAP (mm Hg) HR (bpm) Serum Na+ (mmol/l) Serum K+ (mmol/l) PRA (ng/ml/h) PRC (ng/ml/h) Water intake (ml/day/25 g body wt)
Group
Tap water (n=10) 116±2 606±14 152±1 4.6±0.1 5.5±1.3 387±87 6.3±0.3
DOCA/salt (n=9) 113±2 586±09 153±1 3.1±0.1** 0.9±0.6* 35±25*** 27.4±1.3***
DOCA/salt+K (n=9) 112±3 584±10 154±1 4.4±0.1 2.1±1.2* 91±44** 31.1±1.2***
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studies, two or three arteriolar segments (with diameters ranging from
20 to 60 mm) were chosen either from the immediate proximity of bi-
furcations (to facilitate repeated identiﬁcation of the same vessel seg-
ment) or at a distance of more than 300 μm from bifurcations. After
an equilibration period of 30 min following the start of the tissue
superfusion, the arteriolar segments were observed at 100×magniﬁca-
tion (10× inﬁnity plan achromatic objective, 10×/0.25, with subse-
quent 10-fold numeric magniﬁcation) for 1 min intervals and the
video imageswere recorded on videotape using a 1-chip, color, CCD cam-
era (TK-C1381; JVC) and a standard hard disk video recorder (NV-HS900;
Panasonic). Using this technical setup, a minimal detectable size differ-
ence of the microvascular segments of 1 μm can be reliably identiﬁed.
The same arteriolar vessel segments – thoroughly documented onmicro-
vascular maps that were generated for each animal from videotaped
low-magniﬁcation chamber overviews – were observed again after a
5 min superfusion period with acetylcholine in increasing concentra-
tions (0.1–10 mM) and, following a 10 min recovery period, after a
5-min superfusion period with S-nitroso-N-acetyl-D,L-penicillamine
(SNAP, 10 mM).
For quantiﬁcation of the intravital microscopic ﬁndings, video still
images were imported at a resolution of 72 dpi into Photoshop (Adobe,
San Jose, CA, version CS2) run on aMacintosh G4 computer (Apple com-
puters, Cupertino, CA). Assessment of microvessel diameters was
performed using Photoshop-based image analysis as descried previously
(Brunner et al., 2000). A total of ﬁve measurements were taken per ves-
sel segment and time point, andmean values calculated in order to elim-
inate putative outlier data. All data in theﬁgures are rendered asmean±
SD. In analogy to previous publications (Schaefer et al., 2005, 2012),
endothelium-dependent (i.e. acetylcholine-induced) vasorelaxation
was calculated as percent of total endothelium-independent (i.e. SNAP-
induced) vasorelaxation (indicated as ACh/SNAP in Fig. 3). Statistical dif-
ferences betweenmean values of the various treatment groupswere de-
termined using the ANOVA test with post-hoc Newman–Keuls
correction (GraphPad Software, version 5.0, La Jolla, CA).
Results
In analogy to previous observations (Wang et al., 2005), DOCA/salt
treatment for eight weeks resulted in signiﬁcant hypokalemia in uni-
nephrectomized one renin gene mice (Table 1). At the same time,
serum sodium was not changed by DOCA/salt treatment (Table 1).
As expected, no effects of DOCA/salt treatment were observed on
mean arterial blood pressure and on heart rate (Table 1). Potassium
supplementation for three weeks restored serum potassium in
DOCA/salt mice to levels of control mice and did not affect any of
the macrohemodynamic parameters (Table 1).
Acetylcholine superfusion of the chamber tissue under intravital mi-
croscopic observation showed a dose-dependent vasorelaxation of
precapillary resistance arterioles in control mice (black bars in Fig. 2).
From pilot studies during the establishment of the superfusion model,
we have learnt that the highest acetylcholine dose we used in our pres-
ent study causes themaximum of acetylcholine-dependent vasodilation
in control animals, corresponding to roughly 80% of the maximum po-
tential of vasodilation of the vessel segment, induced by amix of papav-
erine, bradykinin and SNAP. We now found that acetylcholine-induced
vasorelaxation was signiﬁcantly inhibited in the DOCA/salt-treated one
renin gene mice (empty bars in Fig. 2). Note that over the entire dose
range of acetylcholine superfusion, the maximal response was less
than half of the response observed in controlmice. Also, the vasorelaxing
response to the NO donor SNAP was blunted by DOCA/salt, albeit much
less so than the response to acetylcholine (Fig. 2). When the relaxing re-
sponses to SNAP and acetylcholine (10 μM)were calculated as a percent
ratio for each mouse, this ratio was reduced by more than 50% in DOCA/
salt mice (Fig. 3), connoting a signiﬁcant attenuation of endothelium-
dependent vasorelaxation. Feeding DOCA/salt‐treated mice for three
weeks prior to the intravital microscopic experiments with potassium
restored endothelium-dependent and ‐independent vasorelaxation
(gray bars in Fig. 2) and the percent ratio of acetylcholine over SNAP-
induced vasorelaxation (gray bar in Fig. 3).
Fig. 1. Dorsal skinfold chambermodel inmice andmicroscope setup. C57BLmicewere chronically instrumentedwith titaniumskinfold chamber in thedorsal skinfold. For intravitalmicroscopy,
themice were positioned in a Plexiglas tube that was placed sideways under the microscope. An intraarterial polyethylene catheter was attached to a pressure transducer (right). All intravital
microscopic examinations of the microcirculation in the observation chambers were performed in awake mice, thus eliminating any putative adverse effects of anesthetic agents.
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Please note that the number of animals in the respective
macrohemodynamic and intravital microscopic measurements is not
always identical, because some animalswere lost after the intravitalmi-
croscopy measurements (n=12 intravital microscopic versus n=9
macrohemodynamic measurements in the DOCA/salt group) or be-
cause the intravital microscopymeasurements could not be reliably an-
alyzed due to edema formation in the chamber (n=9 intravital
microscopic versus n=10 macrohemodynamic measurements in the
control group).
Discussion
The principal ﬁnding of our study is the observation that
endothelium-dependent and – to a lesser extent – endothelium-
independent vasorelaxation are preserved by a potassium diet in
DOCA/salt mice (Figs. 2, 3), independent of confounding anti-
hypertensive effects (Table 1) This ﬁnding is novel in that none of
the prior experimental approaches used by various groups in the
past have been able to separate putative antihypertensive effects of
potassium from its direct effects on endothelium-dependent vasore-
laxation. In that respect, we believe that our study conﬁrms, and in
a way complements the observations by Wu and coworkers, who
showed that feeding DOCA/salt treated rats potassium in the form
of a diet rich in milk minerals restored acetylcholine-induced relaxa-
tion in aortic rings ex vivo (Wu et al., 1996). The combined use of
DOCA/salt mice and intravital microscopy has now allowed to elimi-
nate not only putative macrohemodynamic effects (Table 1), but
also potentially confounding effects of anesthesia. This is particularly
relevant because anesthetic agents have previously been found to im-
pact on nitric oxide independent acetylcholine-induced endothelial
vasorelaxation (de Wit et al., 1999).
As shown in Table 1, the potassium serum levels in the DOCA/
salt+potassium treated animals were well in the range of the potassi-
um levels measured in control animals. In fact, the small difference of
potassium levels in the different groups is unlikely to have a direct op-
erative effect on smooth muscle relaxation, such as hyperpolarization
via opening of KCa++‐channels. Furthermore, opening/rectifying in-
ward K+ channels or a transient stimulation of the electrogenic Na/K
pump, that can be seen in smaller immediate elevations of extracellular
K+, is likely not operative in our model. Therefore, we propose that po-
tassium supplementation might restore vasorelaxation through as yet
unknown indirect effects, which might include reduction of vascular
oxidative stress (Matsui et al., 2006) or other mechanisms. Endothelial
nitric oxide release is dependent on various cofactors such as
tetrahydrobiopterin (BH4), which is important to keep the eNOS in a
coupled state. DOCA/salt treatment decreases BH4 levels in hyperten-
sive mice which results in eNOS uncoupling and increased O2− produc-
tion (Du et al., 2008; Xie et al., 2010). The reduction of BH4 in DOCA/salt
hypertensive mice has been discussed to be due to a reduced de novo
synthesis and/or increased oxidation to BH3. Administration of BH4 in
combination with the NADPH inhibitor apocynin has been shown to in-
crease the bioavailability of NO via eNOS recoupling in aortic rings of
DOCA/salt hypertensive mice ex vivo (Youn et al., 2012). These results
provide a possible explanation why vasorelaxation in response to ace-
tylcholine was attenuated in the DOCA/salt treated mice in our study.
One of the key attributes of the present study is the fact that we used
intravital microscopy (Fig. 1) to study precapillary resistance arterioles,
which are relevant for blood pressure regulation, and not conductance
vessels, which are frequently examined ex vivo. These large-caliber ves-
sels, such as aortic or carotid rings, differ not only in terms of anatomical
structure, but also in terms of functionality, including the endothelial
control over vascular tone (Mulvany and Aalkjaer, 1990). Based on the
ﬁndings in mouse coronary vessels, Guillot et al. (1999) identiﬁed vas-
cular bed-speciﬁc pathways of eNOS regulationwith striking differences
in eNOS gene expression betweenmicrovessels (strong uniform expres-
sion) and larger arteries (patchy expression with accentuation around
Fig. 2. Increase of diameters of precapillary resistance arterioles in response to
superfusion with various doses of acetylcholine (ACh, 0.1–10 μM) or SNAP (10 μM).
Data are shown as percent increase over baseline values. Data are mean±SD of 9–12 an-
imals per group. Black bars indicate control mice, white bars DOCA/salt treated mice, and
gray bars DOCA/salt+potassium treated mice. Note that potassium normalizes the
endothelium-dependent as well as the endothelium-independent vasorelaxation in
DOCA/salt mice to levels of untreated control mice. Asterisks indicate statistically signiﬁ-
cant differences at the *Pb0.05 and **Pb0.01 level.
Fig. 3. Normalization of endothelium-dependent and endothelium-independent vasore-
laxation in DOCA/salt treated mice by potassium administration. Shown in this graph is
the ratio of acetylcholine (ACh) over SNAP-induced vasorelaxation at doses of 10 μM
(both agents). Note that DOCA/salt signiﬁcantly suppresses endothelium‐dependent va-
sorelaxation, as evidenced by a marked drop of the Ach/SNAP ratio, and that this effect
is effectively counteracted by the potassium diet to levels of control animals. Data are
mean±SD of n=9 control mice (black bars), n=12 DOCA/salt mice (white bars) and
n=9 DOCA/salt mice with the potassium diet (gray bars). The asterisk denotes a statisti-
cally signiﬁcant difference betweendata in DOCA/saltmice and control mice and between
data in DOCA/salt mice with or without the potassium diet at the *Pb0.05 level.
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branching sites). Parent and coworkers found that inhibiting NO synthe-
sis selectively reduced acetylcholine‐induced vasodilatation in cardiac
resistance vessels of dogs, but failed to prevent similar responses in con-
ductance coronary vessels (Parent et al., 1996). Recently, our group has
shown, using the same mouse model as applied in the present study,
that angiotensin-II-mediated hypertension (2 kidney/1 clip Goldblatt
model) leads to endothelium-dependent vasodysfunction in precapillary
resistance arterioles, while this effect could not be reproduced in rings of
large caliber conductance vessels from the same animals ex vivo
(Schaefer et al., 2012).
Can the observationsmade in themice of our study be translated into
a hypertensive organism? Tobian and colleagues have shown that
stroke-prone SHR and Dahl salt sensitive hypertensive rats fed a high
potassium diet had a signiﬁcant reduction in death rate even though
blood pressure was similar in the low and high potassium diet groups
(Sugimoto et al., 1988; Tobian et al., 1985). The precise mechanism by
which dietary potassium reduces death has yet to be demonstrated.
One could speculate that dietary potassium might protect the integrity
of endothelial cells even when they are under heightened stress from
the elevated blood pressure, thus preventing artery wall lesions with
subsequent cerebral hemorrhage and infarcts. We have demonstrated
previously that DOCA/salt induces cardiac and renal hypertrophy,
hypokalemia and metabolic alkalosis independent of blood pressure in
1‐renin gene mice. Correction of hypokalemia and metabolic alkalosis
by dietary potassium supplementation can prevent the development
of renal and cardiac hypertrophy, as well as vascular remodeling
(unpublished data) in normotensive, 1‐renin gene mice that receive ex-
cess mineralocorticoid and salt (Wang et al., 2002, 2005). Nevertheless,
the exact mechanisms of renal and cardiovascular protection by dietary
potassium in human hypertension are currently still unclear and subject
of ongoing clinical trials (effects of potassium salts on blood pressure
and target organ damage and potassium intake in patients with chronic
kidney disease; http://clinicaltrials.gov/ct2/show/NCT00949585). Finally,
we should note thatwith the choice of the particular animalmodel in our
study we wanted to speciﬁcally resolve an experimental dilemma (anti-
hypertensive versus direct pharmacological effects of a potassium-
enriched diet on endothelium‐dependent vasorelaxation in resistance
vessels), and not present an exact animal model of a speciﬁc human
disease.
In conclusion, the present experiments conﬁrm a salutary role of die-
tary potassium on endothelium-dependent vasorelaxation.We speculate
that the cardioprotection by potassium might be mediated by putative
antioxidant effects (Matsui et al., 2006), ameliorating the availability/
efﬁcacy of NO and its well-established cardioprotector actions (Li and
Förstermann, 2000).
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